Alira Health

Alira Health

ISPOR Europe

November 12 - 15 | Copenhagen, Denmark

We are pleased to announce that we will attend and present at ISPOR Europe, the leading global conference in Europe for Health Economics and Outcomes Research (HEOR). This must-attend event brings the opportunity to network with HEOR experts and thought leaders and to discuss how we establish, incentivize, and share value that is sustainable for health systems, patients, and technology developers.

At Alira Health, our expert team offers strategic consulting in access, evidence generation, and pricing strategies and management to maximize commercial success. We support clients from early stages of development through value communication, including HEOR, Real-World Evidence (RWE), and go-to-market strategies.

At ISPOR, we will present an outstanding 27 posters. We are proud that three of our posters are Top 5% Finalists for the ISPOR 2023 Research Presentation Awards. Make sure you do not miss them! Check below for all topics and presentation times.

Events
Published on:
October 11, 2023

Lupus, State of the Art
Poster Title Time & Date Authors
Harnessing the Potential of Natural-Language Processing and Interconnected Data Streams for Complex Diseases in the Hospital Setting: Lupus Case Study in France (LUPUS REAL) 13 November, 11:30 – 12:15 Jouve M, Lagonotte E, Valette M, Sano B, Ricci JF, Vuiblet V
Comparative Analysis of Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus: A Nationwide US Medicare Perspective 13 November, 16:00 – 17:00 Gerstley H, Buser H, Wilson B, Nair A, Delise B, Ricci JF
Prevalence and Burden of Lupus in Adult French Population: A Retrospective Longitudinal National Hospital Claims Study 13 November, 16:00 – 17:00 Cohen N, Petrica N, Ricci JF, Rose M
Characterization of Comorbidities and Economic Burden in US Medicare Beneficiaries with Systemic Lupus Erythematosus with and without Lupus Nephritis 14 November, 12:30 – 13:30 Nair A, Wilson B, Buser H, Gerstley H, Ricci JF, Delise B
Characterization of the Lupus Patient Experience Based on Longitudinal Patient Generated Real World Data from a Digital Health App (HEALTH STORYLINES) 14 November, 16:00 – 17:00 Willmon R, Vivaldi V, Ricci JF
Epidemiology and Burden of Illness of Lupus in Children by Form of Lupus: A Retrospective Longitudinal National Hospital Claims Study in France 14 November, 15:30 – 16:15 Cohen N, Petrica N, Sano B, Ricci JF, Rose M

*Top 5% Finalist for the ISPOR 2023 Research Presentation Awards

French Ecosystem Access and HEOR Trends
Poster Title Time & Date Authors
New Pathway in Anti-HER2 Treatments’ Administration in Breast Cancer in France: Which Impacts of the Involvement of an Advanced Practice Nurse in Hospital at Home Program? 14 November, 12:30 – 13:30 Pozzar M, Couillerot AL, Gherardi A, Marchand L, Le Lay K, Pallaro S, Bigas M, Maillan G, Deluche E
Handling Uncertainty in Health-Economic Assessments: Experience From COVID-19 in France 14 November, 12:30 – 13:30 Autin E, Pozzar M, Couillerot AL
Single-arm Studies in Rare Diseases and Statistical Methods to Mitigate Lack of Comparative Data: What Kind of Assessment is More Successful for the French HTA Body? 14 November, 12:30 – 13:30 Belamri M, Yahia A, Pozzar M, Couillerot AL
Burden of the Disease and Management in COVID-19 Hospitalized Patients in MSO and Home Care in France: COVID-Hosp Study (2020-2022) 14 November, 16:00 – 17:00 Pozzar M, Petrica N, Ben Romdhane H, Fiévez S, Crépey P, Mongazon-Cazavet M
Factors Having an Impact on the Prescription of Cancer Treatments in Hospital at Home Program in Bronchopulmonary Cancer: A French Claims Database Analysis (2016-2021) 14 November, 16:00 – 17:00 Pozzar M, Couillerot AL, Rosé M, Sano B, Petrica N
Impact of ASMR Changes on List Prices: An Analysis of HAS Re-Evaluations 15 November, 9:00 – 10:00 Dumoulin O, Bordoy Coma-Cros C, Pozzar M, Zhu Jin XW

Value-Based Contracts
Poster Title Time & Date Authors
Value-based Contract Types Across Global Healthcare Systems: Comparing Perceptions Between Finance-based and Outcomes-based Agreements 15 November, 9:00 – 10:00 Mestre-Ferrandiz J, Pascual-Argente N, Dumoulin O, Sathi C, Bento G, Grandy A,
Chouman S, Towle P
Optimizing Healthcare Outcomes: Identifying the Conditions for Successful Value-based Contracts 14 November, 16:00 – 17:00 Dumoulin O, Sathi C, Bento G, Grandy A, Mestre-Ferrandiz J, Pascual-Argente N
Qualitative Analysis of Value-based Contract (VBCs) Experience, Perception, and Future Adoption Across Geographies 13 November, 12:30 – 13:30 Sathi C, Dumoulin O, Bento G, Grandy A, Mestre-Ferrandiz J, Pascual-Argente N

*Top 5% Finalist for the ISPOR 2023 Research Presentation Awards

Hot Topics in MedTech Access
Poster Title Time & Date Authors
The Comparative Analysis of Accelerated Coverage Pathways for Innovation (ACPI) for Digital Technologies 13 November, 16:00 – 17:00 Ramkeesoon A, Ben Dhia O
Incorporating environmental sustainability considerations into national HTA assessments 14 November, 12:30 – 13:30 Tsantila S

Other Topics
Poster Title Time & Date Authors
Exploring the Value of RWD Collected From Early Access Programs to Support HTA Decision-Making 13 November, 16:00 – 17:00 Proenca C, Badinedi R, Godbole M, Petrica N
Resource Use Associated with Alpelisib for the Treatment of Patients with Pros: A Modeling Approach 14 November, 12:30 – 13:30 Petrica N, Cottard K, Foss P, Palladino S, Yasar N, Ricci JF
Cost-Effectiveness of the PPARy Modulator N-Acetyl-Ged-0507-34-Levo (NAC-GED 5%) Versus Benzoyl Peroxide-Adapalene for Moderate to Severe Acne 14 November, 16:00 – 17:00 Matos T, Godbole M, Grandy A, Demont E, Viti F, Bellinvia S, Zambeletti L, Sebaratnam D
Support of RWE in the Price and Reimbursement Decision-Making Process for Rare Diseases in Spain 14 November, 16:00 – 17:00 Saborido CM, Calleja MA, Martínez Sesmero JM, Piñol FS, Fontanet M, Castillo C, de la Paz Cañizares I, Hernaez Colque M, Asensio I, Ferrández O
Psychological Burden in People Living with Myasthenia Gravis: Prevalence and Associated Risk Factors of Depression and Anxiety from the MGFA Global MG Patient Registry (MGFAPR) in the US (2017-2022) 14 November, 16:00 – 17:00 Park M ,Sangha O, Gwathmey K, Ricci JF, Zurinaga A, Willmon R
Exploring the Perceived Value of Fixed-Dose Combinations in Type 2 Diabetes in the EU4 and the UK 14 November, 16:00 – 17:00 Cruz Arrioja JC, Zaniboni B, Yeoh L, Reinert M, Naser R, Mos J, Gulotta G
Treatment Approvals in Oncology and Relationship with Improvement in 5-Year Relative Survival for Cancer Patients in Europe 15 November, 9:00 – 10:00 Gulotta G, Reinert M, Mos J, Naser R, Dumoulin O, Yeoh L, Cruz Arrioja JC, Zaniboni B

Our Delegates

Nerea Blanqué-Catalina

Managing Partner, Consulting Affiliates
Jean-François Ricci

Jean-Francois Ricci

Chief Access Officer, Real World Solutions
Chus Castillo

Chus Castillo

Partner, Consulting Iberia
Andrea Mantovani

Andrea Mantovani

Partner, Consulting Pharma
Catia Proenca

Catia Proenca

Director, Real World Solutions
Nicoleta Petrica

Nicoleta Petrica

Associate Director, Evidence Generation Studies
Elodie Lehmann

Elodie Lehmann

Associate Director, Real World Solutions
Isabel De La Paz

Isabel de la Paz

Associate Director, Consulting Iberia

Giuseppe Gulotta

Principal, Consulting Pharma
Aina Pi

Aina Pi

Engagement Manager, Global Market Access
Alexa Vidalis

Alexa Vidalis

Senior Consultant, Global Market Access
Anastasia Amato

Anastasia Amato

Senior Consultant, Consulting Pharma
Xiao Wei Zhu

Xiao Wei Zhu

Senior Consultant, Global Pharma

Benedetta Zaniboni

Consultant

Célia Sathi

Consultant, Global Market Access

Anjali Ramkeesoon

Associate Consultant, MedTech Market Access & Commercial Strategy

Batourou Sano

Associate Consultant, Evidence Generation Studies

Kabisan Thanendran

Associate Consultant, MedTech Market Access & Commercial Strategy
Mario Pozzar

Mario Pozzar

Associate Consultant, Consulting France

Mrunmayee Godbole

Associate Consultant, Evidence Generation Studies
Ons Ben Dhia

Ons Ben Dhia

Associate Consultant, MedTech Market Access & Commercial Strategy

Rithvik Badinedi

Associate Consultant, Evidence Generation Studies

Stelina Tsantila

Associate Consultant, MedTech Market Access & Commercial Strategy

Sarah Nathens

Analyst, MedTech Market Access & Commercial Strategy

Tiago Matos

Associate Director, Global HEOR

Elise Demont

Consultant, Consulting Pharma

Aaron Grandy

Associate Director, Global Market Access
Hannah Buser

Hannah Buser

Engagement Manager
Ben Wilson

Ben Wilson

Principal, Artisan Healthcare Consulting, an Alira Health Company
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.